Our intern Emi Miyashita (CiRA, Kyoto Univ.) developed a new method for detecting specific RNA structures and presented the research results at the 22nd Annual Meeting of the RNA Society of Japan. This research received the EMBO Reports Award.
Title: Motif-MaP detects RNA higher-order structures by mutational profiling using target-binding small molecules
Click here for more information
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.